+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Proton Pump Inhibitor"

From
Proton Pump Inhibitors Market Report 2025 - Product Thumbnail Image

Proton Pump Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Proton Pump Inhibitors (ppis) Market 2025-2029 - Product Thumbnail Image

Proton Pump Inhibitors (ppis) Market 2025-2029

  • Report
  • January 2025
  • 199 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Peptic Ulcer Drugs - Global Strategic Business Report - Product Thumbnail Image

Peptic Ulcer Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
From
Geriatric Medicines - Global Strategic Business Report - Product Thumbnail Image

Geriatric Medicines - Global Strategic Business Report

  • Report
  • April 2025
  • 304 Pages
  • Global
From
Antacids - Global Strategic Business Report - Product Thumbnail Image

Antacids - Global Strategic Business Report

  • Report
  • April 2025
  • 486 Pages
  • Global
From
Gastric Ulcers Market Report 2025 - Product Thumbnail Image

Gastric Ulcers Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Loading Indicator

Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea. PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers. Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more